GALT
USDGalectin Therapeutics Inc. Common Stock
$5.670-0.310 (-5.184%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$5.980
High
$6.250
Low
$5.550
Volume
0.50M
Company Fundamentals
Market Cap
365.6M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.31M
Exchange
NCM
Currency
USD
52-Week Range
Low $0.73Current $5.670High $6.55
Related News
Analyst Upgrades
HC Wainwright & Co. Reiterates Buy on Galectin Therapeutics, Maintains $6 Price Target
HC Wainwright & Co. analyst Matthew Keller reiterates Galectin Therapeutics with a Buy and maintains $6 price target.
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.